Duggan Robert W Insider Trades

Insider Trading History

Track insider trading activity for Duggan Robert W. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pulse Biosciences
Pulse Biosciences PLSE
10% owner
Holding Value $1.3B 48,370,047 shares
Last Trade
May 11, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13M 660,233 shares
$19.69
$26.94
Pulse Biosciences
Pulse Biosciences PLSE
10% owner
Holding Value $1.3B 48,211,433 shares
Last Trade
May 11, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13M 660,233 shares
$19.69
$26.94
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $167k 11,232 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$197k 11,232 shares
$17.52
$14.84
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $1.14M 76,680 shares
Last Trade
Oct 21, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$500k 26,680 shares
$18.74
$14.84
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $8.46B 570,073,879 shares
Last Trade
Oct 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$262M 13,980,789 shares
$18.74
$14.84
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $382M 25,724,474 shares
Last Trade
Oct 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5M 266,808 shares
$18.74
$14.84
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $8.25B 556,093,090 shares
Last Trade
Sep 11, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$90.4k 5,000 shares
$18.07
$14.84
Pulse Biosciences
Pulse Biosciences PLSE
10% owner
Holding Value $1.28B 47,551,200 shares
Last Trade
Sep 10, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$508k 34,659 shares
$14.66
$26.94
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $8.25B 556,088,090 shares
Last Trade
Sep 10, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.89M 333,394 shares
$17.68
$14.84
Pulse Biosciences
Pulse Biosciences PLSE
10% owner
Holding Value $808k 30,000 shares
Last Trade
Aug 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$821k 50,792 shares
$16.16
$26.94
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $8.25B 555,754,696 shares
Last Trade
May 30, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.36M 74,545 shares
$18.22
$14.84
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $0 0 shares
Last Trade
May 30, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.36M 74,545 shares
$18.22
$14.84
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $142M 9,590,558 shares
Last Trade
Apr 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$266M 11,030,558 shares
$24.11
$14.84
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $8.25B 555,680,151 shares
Last Trade
Apr 08, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$66.3M 3,985,055 shares
$16.64
$14.84
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $0 0 shares
Last Trade
Apr 08, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$66.3M 3,985,055 shares
$16.64
$14.84
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $159k 10,724 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$197k 10,724 shares
$18.35
$14.84
Pulse Biosciences
Pulse Biosciences PLSE
10% owner
Holding Value $1.28B 47,516,541 shares
Last Trade
Dec 18, 2024 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$102M 5,306,156 shares
$19.24
$26.94
Pulse Biosciences
Pulse Biosciences PLSE
10% owner
Holding Value $0 0 shares
Last Trade
Dec 18, 2024 Sale (In The Money)Reported as In The Money on SEC Form 4.
$474k 24,656 shares
$19.24
$26.94
Pulse Biosciences
Pulse Biosciences PLSE
10% owner
Holding Value $1.14B 42,328,717 shares
Last Trade
Dec 13, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$949k 55,256 shares
$17.18
$26.94
Pulse Biosciences
Pulse Biosciences PLSE
10% owner
Holding Value $1.14B 42,228,057 shares
Last Trade
Dec 11, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$973k 56,054 shares
$17.35
$26.94

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up